NYMOX PHARMACEUTICAL CORP
Nymox Pharmaceutical Corporation specializes in the research and development of therapeutics and diagnostics, with a focus on products targeted for the unmet needs of the rapidly aging male population. Their lead drug candidate, Fexapotide Triflutate (FT), has completed Phase 3 development for BPH. The company is also developing FT for early-stage prostate cancer (PCA). Nymox is preparing for regulatory approval filings in major economies.
Officielt Register
Sidst verificeret: 1/2/2026
AI Kvalitetsanalyse
Tillidsscore Detaljer
Genveje
Hjemmeside Højdepunkter
🌟 Lignende Troværdige Virksomheder
Lantern Pharma Inc.
Lantern Pharma is an AI-driven company focused on transforming oncology drug discovery and development. Leveraging their proprietary RADR® platform, which utilizes ~200 billion oncology-focused data points and advanced ML algorithms, they accelerate the creation of precision therapies. Their pipeline includes drug candidates across multiple cancer indications, with one in Phase 2 clinical testing, aiming to reduce costs and timelines. They collaborate with various institutions to advance their AI precision oncology platform.
Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals aims to be a leading innovator in the self-care market, driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options. They focus on enhancing consumer reach to medications via OTC drug programs and democratizing healthcare by making medications more accessible without a prescription.
OVATION SCIENCE INC.
Ovation Science Inc. is capitalizing on its patented Invisicare® skin delivery technology, disrupting the topical market with its advanced science. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. The company is an innovative player in drug delivery systems.